Stockholm - Delayed Quote SEK
SynAct Pharma AB (SYNACT.ST)
18.26
-0.48
(-2.56%)
At close: May 13 at 5:29:29 PM GMT+2
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | 1 | 1 |
Avg. Estimate | 0 | 0 | -1.5 | 2.5 |
Low Estimate | 0 | 0 | -1.5 | 2.5 |
High Estimate | 0 | 0 | -1.5 | 2.5 |
Year Ago EPS | -- | -- | -2.08 | -1.5 |
Revenue Estimate
Currency in SEK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 1 |
Avg. Estimate | -- | -- | -- | 258.1M |
Low Estimate | -- | -- | -- | 258.1M |
High Estimate | -- | -- | -- | 258.1M |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | -- | -- | 0.00% | 0.00% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | -1.5 | 2.5 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | 1 | -- |
Up Last 30 Days | -- | -- | 1 | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
SYNACT.ST | -- | -- | 27.88% | 266.67% |
S&P 500 | 13.17% | 3.05% | 8.05% | 13.75% |
Related Tickers
P0F.F Egetis Therapeutics AB (publ)
0.3335
+8.99%
GENO.ST Genovis AB (publ.)
24.00
-2.83%
XSPRAY.ST Xspray Pharma AB (publ)
32.60
-2.54%
EGTX.ST Egetis Therapeutics AB (publ)
3.6500
-4.82%
KAN.ST Kancera AB (publ)
1.0520
-0.57%
ELIC.ST Elicera Therapeutics AB (publ)
5.0000
+5.37%
ACE.ST Ascelia Pharma AB (publ)
3.8850
-0.38%
DMYD-B.ST Diamyd Medical AB (publ)
9.11
-0.98%
SANION.ST Saniona AB (publ)
7.92
-1.98%
BIOA-B.ST BioArctic AB (publ)
172.00
-2.38%